Immune quiescence: a model of protection against HIV infection.
about
Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.How can we design better vaccines to prevent HIV infection in women?Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 ReplicationThe Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon InfectionBlocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues.Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 InfectionReducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.Improving Adherence to Post-Cervical Biopsy Sexual Abstinence in Kenyan Female Sex WorkersHighly-Exposed HIV-1 seronegative Female Commercial Sex Workers sustain in their genital mucosa increased frequencies of tolerogenic myeloid and regulatory T-cells.Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract
P2860
Q33602772-74A45EB2-22F4-4522-8CD2-BF4494BDF696Q33613121-310455AD-9141-4DC6-A924-8848D7E0EA9DQ34449068-448AD9D1-42B4-4102-99C4-CB49C4879237Q35174468-830393AD-995B-4AF8-BF38-EE0D711544A5Q36466553-CC88E10B-A7E8-4CEE-92CD-2F91D4A8C8F4Q36625426-12714647-7DAF-484D-91BA-9B76409F6155Q36678079-575466E3-7478-4F9E-839F-66DC58349988Q36900870-83E5AD57-8CA6-42BE-A111-0B0052ABBD0CQ36939732-FF8BDFD7-5207-44F6-A163-07E44125F1B6Q37385006-D5E14695-B63E-4A4A-A090-99F2B88B4440Q37682197-F367D40C-14CB-408E-871A-DF73266FAB73Q40047164-52B4BA88-E5D2-4379-AC38-25CD65B5D29CQ40891066-5D3C9DDE-9BFC-4D20-B8FC-81D7372B5EA7Q42241791-19076F15-2FFF-43F1-A32E-5337BFEA9993Q45812682-2BE189D3-E2BF-49EC-8DC1-AE8D06F5B66EQ56978353-F2DE3E1B-2C39-4308-B024-D0745A6C28D5
P2860
Immune quiescence: a model of protection against HIV infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Immune quiescence: a model of protection against HIV infection.
@en
Immune quiescence: a model of protection against HIV infection.
@nl
type
label
Immune quiescence: a model of protection against HIV infection.
@en
Immune quiescence: a model of protection against HIV infection.
@nl
prefLabel
Immune quiescence: a model of protection against HIV infection.
@en
Immune quiescence: a model of protection against HIV infection.
@nl
P2860
P921
P356
P1433
P1476
Immune quiescence: a model of protection against HIV infection.
@en
P2093
Catherine M Card
Terry Blake Ball
P2860
P2888
P356
10.1186/1742-4690-10-141
P50
P5008
P577
2013-11-20T00:00:00Z
P5875
P6179
1021092200